We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Instrument for Spine Surgery

By HospiMedica staff writers
Posted on 26 Sep 2005
A new surgical instrument called the insulated pedicle access system, or I-PAS, is for use in determining the safe percutaneous approach pathway of a pedicle screw prior to its implantation.

The I-PAS is designed for use in conjunction with the nerve-avoidance software of NuVasive, Inc. More...
(San Diego, CA, USA), called NeuroVision. Performing a dynamic test gives a surgeon constant feedback about the proximity of surrounding nerves in the screw's pathway, allowing a safe approach into the vertebral body and avoiding the needle to allow a subsequent implant, such as NuVasive's SpheRx DBR, to pass safely over the guide wire into the pedicle. NuVasive said this is the first percutaneous and dynamic neurophysiology system on the market to continuously monitor and alleviate the risk of neurologic injury. The added detection offered by I-PAS also allows for less fluoroscopy during surgery, which is beneficial to both surgeon and patient.

"We believe I-PAS provides surgeons with a substantial tool to increase the safety of the procedure while adding intra-operative efficiency,” noted Alexis V. Lukianov, chairman and CEO of NuVasive. "The launch of I-PAS is consistent with our vertical integration strategy of providing products that increase penetration of our MAS platform among spine surgeons.”

The MAS platform combines three products: NeuroVision, the nerve-avoidance system; MaXcess, a split-blade design retraction system; and specialized implants, such as SpheRx and CoRoent, which collectively minimize soft tissue disruption during spine surgery.




Related Links:
NuVasive

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.